These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1011 related articles for article (PubMed ID: 29254508)
1. Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment. Steggerda SM; Bennett MK; Chen J; Emberley E; Huang T; Janes JR; Li W; MacKinnon AL; Makkouk A; Marguier G; Murray PJ; Neou S; Pan A; Parlati F; Rodriguez MLM; Van de Velde LA; Wang T; Works M; Zhang J; Zhang W; Gross MI J Immunother Cancer; 2017 Dec; 5(1):101. PubMed ID: 29254508 [TBL] [Abstract][Full Text] [Related]
2. Arginase 1-Based Immune Modulatory Vaccines Induce Anticancer Immunity and Synergize with Anti-PD-1 Checkpoint Blockade. Aaboe Jørgensen M; Ugel S; Linder Hübbe M; Carretta M; Perez-Penco M; Weis-Banke SE; Martinenaite E; Kopp K; Chapellier M; Adamo A; De Sanctis F; Frusteri C; Iezzi M; Zocca MB; Hargbøll Madsen D; Wakatsuki Pedersen A; Bronte V; Andersen MH Cancer Immunol Res; 2021 Nov; 9(11):1316-1326. PubMed ID: 34518197 [TBL] [Abstract][Full Text] [Related]
3. Breast cancer-derived GM-CSF regulates arginase 1 in myeloid cells to promote an immunosuppressive microenvironment. Su X; Xu Y; Fox GC; Xiang J; Kwakwa KA; Davis JL; Belle JI; Lee WC; Wong WH; Fontana F; Hernandez-Aya LF; Kobayashi T; Tomasson HM; Su J; Bakewell SJ; Stewart SA; Egbulefu C; Karmakar P; Meyer MA; Veis DJ; DeNardo DG; Lanza GM; Achilefu S; Weilbaecher KN J Clin Invest; 2021 Oct; 131(20):. PubMed ID: 34520398 [TBL] [Abstract][Full Text] [Related]
4. Suppression of Myeloid Cell Arginase Activity leads to Therapeutic Response in a NSCLC Mouse Model by Activating Anti-Tumor Immunity. Miret JJ; Kirschmeier P; Koyama S; Zhu M; Li YY; Naito Y; Wu M; Malladi VS; Huang W; Walker W; Palakurthi S; Dranoff G; Hammerman PS; Pecot CV; Wong KK; Akbay EA J Immunother Cancer; 2019 Feb; 7(1):32. PubMed ID: 30728077 [TBL] [Abstract][Full Text] [Related]
5. Arginase 1 is a key driver of immune suppression in pancreatic cancer. Menjivar RE; Nwosu ZC; Du W; Donahue KL; Hong HS; Espinoza C; Brown K; Velez-Delgado A; Yan W; Lima F; Bischoff A; Kadiyala P; Salas-Escabillas D; Crawford HC; Bednar F; Carpenter E; Zhang Y; Halbrook CJ; Lyssiotis CA; Pasca di Magliano M Elife; 2023 Feb; 12():. PubMed ID: 36727849 [TBL] [Abstract][Full Text] [Related]
6. A Novel Oral Arginase 1/2 Inhibitor Enhances the Antitumor Effect of PD-1 Inhibition in Murine Experimental Gliomas by Altering the Immunosuppressive Environment. Pilanc P; Wojnicki K; Roura AJ; Cyranowski S; Ellert-Miklaszewska A; Ochocka N; Gielniewski B; Grzybowski MM; Błaszczyk R; Stańczak PS; Dobrzański P; Kaminska B Front Oncol; 2021; 11():703465. PubMed ID: 34504786 [TBL] [Abstract][Full Text] [Related]
7. Myeloid Cell-Derived Arginase in Cancer Immune Response. Grzywa TM; Sosnowska A; Matryba P; Rydzynska Z; Jasinski M; Nowis D; Golab J Front Immunol; 2020; 11():938. PubMed ID: 32499785 [TBL] [Abstract][Full Text] [Related]
8. Polymorphonuclear-MDSCs Facilitate Tumor Regrowth After Radiation by Suppressing CD8 Zhang Md J; Zhang Md L; Yang Md Y; Liu Md Q; Ma Md H; Huang Md A; Zhao Md Y; Xia Md Z; Liu Md T; Wu Md G Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1533-1546. PubMed ID: 33238192 [TBL] [Abstract][Full Text] [Related]
9. FFAR2 expressing myeloid-derived suppressor cells drive cancer immunoevasion. Zhao Z; Qin J; Qian Y; Huang C; Liu X; Wang N; Li L; Chao Y; Tan B; Zhang N; Qian M; Li D; Liu M; Du B J Hematol Oncol; 2024 Feb; 17(1):9. PubMed ID: 38402237 [TBL] [Abstract][Full Text] [Related]
10. Arginase-1 specific CD8+ T cells react toward malignant and regulatory myeloid cells. Glöckner HJ; Martinenaite E; Landkildehus Lisle T; Grauslund J; Ahmad S; Met Ö; Thor Straten P; Hald Andersen M Oncoimmunology; 2024; 13(1):2318053. PubMed ID: 38404966 [TBL] [Abstract][Full Text] [Related]
11. IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice. Bronte V; Serafini P; De Santo C; Marigo I; Tosello V; Mazzoni A; Segal DM; Staib C; Lowel M; Sutter G; Colombo MP; Zanovello P J Immunol; 2003 Jan; 170(1):270-8. PubMed ID: 12496409 [TBL] [Abstract][Full Text] [Related]